Do you want to volunteer for Clinical Trials? Register now

Volunteer for Clinical Trials

Have you ever thought about taking part in a Medical Trial? By registering your details with MedTrials.co.uk, we are able to send your details directly to companies who are looking for volunteers to take part in their medical research studies.

Information about you is kept on a register that CROs, Pharmaceutical companies and Clinical Investigators can access to contact you regarding individual studies.

Register now >

Merck & Co to buy Afferent for up to $1.25 billion

Merck & Co is buying clinical-stage biotech Afferent Pharmaceuticals in a deal worth up to $1.25 billion.

Go to Source

Leave a Reply

News

Clinical trial shows some promise for Duchenne muscular dystrophy drug

The results of an international clinical trial, led in part by a UC Davis School of Medicine expert, have shown that a drug therapy for a severe type of muscular dystrophy holds promise for a… Powered by WPeMatico

more >

Exclusion of mothers-to-be from clinical studies unfair and potentially harmful

The widely accepted principle that mums-to-be are a ‘vulnerable’ group unfairly excludes them from taking part in clinical studies, and perpetuates the knowledge void around the impact of drugs taken… Powered by WPeMatico

more >

CAR T-cell therapy for leukemia leads to remissions in clinical trial

Researchers at Fred Hutchinson Cancer Research Center showed about 70 percent of patients with the most common adult leukemia had their tumors shrink or disappear following an experimental chimeric… Powered by WPeMatico

more >

Lewis “Lou” Von Thaer named Battelle’s president and CEO

Battelle’s Board of Directors announced that Lewis “Lou” Von Thaer has been selected as president and CEO of Battelle, the 9th CEO in the company’s 87-year history. Von Thaer, who has extensive leadership experience in diverse markets, including engineering, intelligence and other federal contracting sectors, will officially begin his new role on October 1, 2017. He […]

more >

Helius, USAMRMC enroll last subject enrolled in TBI trial

Helius Medical Technologies, a medical technology company focused on the treatment of neurological symptoms caused by disease or trauma, and the United States Army Medical Research and Materiel Command (USAMRMC) announce that the last subject has been enrolled in the registrational clinical trial to investigate the safety and effectiveness of the Portable Neuromodulation Stimulator (PoNS) […]

more >

Sangamo receives FDA Fast Track for SB-318a SB-913

Sangamo Therapeutics announced that the FDA has granted Fast Track designation to SB-318 and SB-913, the company’s clinical stage in vivo genome editing product candidates for the treatment of Mucopolysaccharidosis Type I (MPS I) and MPS II, respectively. The FDA’s Fast Track designation is designed to facilitate the development and expedite the review of drugs and biologics […]

more >